Cat.#: ACPP-1135
| Despition | ACTH Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1765 | Human PQBP1 Protein (AC1765) | 5 µg | inquiry |
| ACPP-1581 | Rat FGF 9 Protein (AC1581) | 2 µg | inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
| ACPP-1642 | ENPP2 Blocking Peptide (AC1642) | 250 µg | inquiry |
| ACPP-1191 | Nogo Blocking Peptide (AC1191) | 250 µg | inquiry |
| ACPP-1034 | Recombinant Human NG2 Protein (6×His Tag) (AC1034) | 50 µg | inquiry |
| ACPP-1169 | proBNP Blocking Peptide (AC1169) | 250 µg | inquiry |
| ACPP-1648 | Human RAMP1 Protein (AC1648) | 2 µg | inquiry |
| ACPP-1474 | Human RGS21 Protein (AC1474) | 5 µg | inquiry |
| ACPP-1400 | ACTH (AC1400) | 2 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.